Retinoids Synergize with Interleukin-2 to Augment IFN-gamma and Interleukin-12 Production by Human Peripheral Blood Mononuclear Cells
- 1 April 1999
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 19 (4) , 407-415
- https://doi.org/10.1089/107999099314117
Abstract
We have demonstrated previously that cells from both the skin and peripheral blood from patients with cutaneous T cell lymphoma (CTCL) have elevated levels of protein and mRNA for Th2 cytokines, interleukin4 (IL-4) and IL-5, and depressed levels of Th1 cytokines, IL-2 and interferon-gamma (IFN-gamma). Furthermore, IL-12 in vitro can restore IFN-gamma production by these patients' cells to near normal levels. Because retinoids exert therapeutic activity in CTCL and are potent modulators of growth and differentiation of hematopoietic cells, we investigated the role of retinoids in modulating Th1 cytokine production. Peripheral blood mononuclear cells (PBMC) from normal donors and patients with CTCL were cultured with medium, IL-2, 13-cis-retinoic acid, all-trans-retinoic acid, acetretin or etretinate alone, or IL-2 plus the retinoids for 24 h, and levels of IFN-gamma were determined using ELISA. IL-2 or retinoids alone could induce low but significant levels of IFN-gamma. However, when IL-2 was cultured with each retinoid, a synergistic augmentation of IFN-gamma levels (4-fold to 90-fold) was observed except in the case of etretinate. All-trans-retinoic acid (ATRA) was the most potent IFN-gamma inducer. Similar studies performed using PBMC from CTCL patients indicated the IFN-gamma augmentation occurred but in a blunted manner. The IFN-gamma-inducing effect of ATRA and 13-cis-retinoic acid could be abrogated by addition of anti-IL-12 antibodies, suggesting that IL-12 plays a role in the synergistic upregulation of IFN-gamma. Using an IL-12 p40-specific radioimmunoassay (RIA), we confirmed the presence of IL-12 in IL-2 plus retinoid-treated culture supernatants. Purified monocytes cultured with IL-2 plus ATRA did not secrete IL-12. Only when monocytes were cocultured with lymphocytes was there an increase in IL-12 production, suggesting the involvement of a paracrine feedback loop requiring both monocytes and lymphocytes. These data suggest that retinoids can induce Th1 cytokines from normal and CTCL PBMC and that this induction may be mediated through IL-12 production.Keywords
This publication has 30 references indexed in Scilit:
- Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell‐mediated inflammation are unexpected outcomesJournal of Cutaneous Pathology, 1996
- Combined modality therapy for cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1996
- A mechanism of retinoid potentiation of murine T-cell responses: Early upregulation of interleukin-2 receptorsInternational Journal of Immunopharmacology, 1993
- Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulationArchives of Dermatology, 1993
- Upregulation by Retinoic Acid of Interleukin-2-Receptor mRNA in Human T LymphocytesCellular Immunology, 1993
- Roferon‐A (interferon alpha 2a) combined with tigason (etretinate) for treatment of cutaneous T cell lymphomasThe International Journal of Cell Cloning, 1993
- All-trans-tetinoic acid and cutaneous cancersJournal of the American Academy of Dermatology, 1986
- Etretinate A Review of its Pharmacological Properties and Therapeutic Efficacy in Psoriasis and Other Skin DisordersDrugs, 1983
- International studies of the efficacy of etretinate in the treatment of psoriasisJournal of the American Academy of Dermatology, 1982
- Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patientsArchives of Dermatology, 1982